Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has shown superior specificity and sensitivity in detecting lymph node and bone metastases compared to conventional imaging [3], while multiparametric (mp) magnetic resonance imaging (MRI) remains the gold standard for detecting intraprostatic tumours and local staging (T-staging). This evidence concerns the gene FOLH1 and neoplasm.